Skip to main content
Top
Published in: Journal of General Internal Medicine 8/2020

01-08-2020 | SARS-CoV-2 | Concise Research Report

Self-Reported Loss of Smell and Taste in SARS-CoV-2 Patients: Primary Care Data to Guide Future Early Detection Strategies

Authors: Benoit Tudrej, MD, PhD, Paul Sebo, MD, MSc, Julie Lourdaux, MD, Clara Cuzin, Martin Floquet, Dagmar M. Haller, MD, PhD, Hubert Maisonneuve, MD, M.Ed

Published in: Journal of General Internal Medicine | Issue 8/2020

Login to get access

Excerpt

While initial reports did not highlight such symptoms, recent data from several countries suggest that SARS-CoV-2-positive inpatients experienced loss of smell and/or taste.1, 2 In a retrospective web-based study of outpatients who had attended one of three emerging diseases center in France, the combination of hyposmia and hypogeusia had moderate sensitivity (42%) and high specificity (95%) for the identification of SARS-CoV-2-positive patients.2 While loss of smell or taste could be a key symptom to guide early identification of new cases in primary care, the extent to which participants in this study were representative of primary care patients is unclear. To address this limitation, we conducted a study involving primary care patients in France. …
Literature
1.
go back to reference Giacomelli A, Pezzati L, Conti F, et al. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2020. Giacomelli A, Pezzati L, Conti F, et al. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2020.
2.
go back to reference Bénézit F, Le Turnier P, Declerck C, et al. Utility of hyposmia and hypogeusia for the diagnosis of COVID-19. Lancet Infect Dis. 2020. Bénézit F, Le Turnier P, Declerck C, et al. Utility of hyposmia and hypogeusia for the diagnosis of COVID-19. Lancet Infect Dis. 2020.
3.
go back to reference Guan W-J, Ni Z-Y, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020. Guan W-J, Ni Z-Y, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020.
4.
go back to reference Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020.
5.
go back to reference Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;15:7264–75.CrossRef Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;15:7264–75.CrossRef
6.
go back to reference Wynants L, Van Calster B, Bonten MMJ, et al. Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal. BMJ. 2020;07;369:m1328. Wynants L, Van Calster B, Bonten MMJ, et al. Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal. BMJ. 2020;07;369:m1328.
Metadata
Title
Self-Reported Loss of Smell and Taste in SARS-CoV-2 Patients: Primary Care Data to Guide Future Early Detection Strategies
Authors
Benoit Tudrej, MD, PhD
Paul Sebo, MD, MSc
Julie Lourdaux, MD
Clara Cuzin
Martin Floquet
Dagmar M. Haller, MD, PhD
Hubert Maisonneuve, MD, M.Ed
Publication date
01-08-2020
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 8/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-05933-9

Other articles of this Issue 8/2020

Journal of General Internal Medicine 8/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.